Did My Hippie Aunt Find a Cure for Epilepsy?

In a small mountain cottage tucked away in the Vermont wilderness, my Aunt Barbara tends to her marijuana plants daily.

Her pot use was a never much of a secret. I knew from early on my aunt enjoyed her fair share of weed.

You could call her a classic hippie.

But as I grew older and more aware, it became clear: She used pot for more than a buzz.

You see, Aunt Barbara is a longtime sufferer of epilepsy. Treatment is limited.

Diagnosed early in childhood, her seizures were quite severe. She was under constant care and supervision. Living in fear of the next attack was her norm.

As an adult the epilepsy continued to hinder her quality life. She never drove, despite having a license. Thankfully, she had the good sense to know it’s too dangerous.

When the family would gather for the holidays, it was never certain if my aunt would be there. Her epilepsy kept her from the family way too often.

We missed out too. Her jovial presence lit up a room, and we always loved her gifts of hand-knitted socks and fancy Vermont maple syrup.

That was then.

Today, Barbara’s found new relief from the ills of her epileptic seizures.

The marijuana she uses to treat her epilepsy is far from the “whacky tobacky” you’re thinking of.

Instead, she grows and uses a genetically engineered strain of marijuana created by biologists and prescribed by her doctor to ease her symptoms.

The specific strain she uses differs from typical marijuana because of its high concentration of cannabidiol (CBD) compared to a very low tetrahydrocannabinol (THC) concentration.

Medical Marijuana 101: CBD Versus THC

Marijuana contains over a hundred active chemical compounds called cannabinoids. The two best known are tetrahydrocannabinol, better known as THC, and cannabidiol, commonly referred to as CBD.

THC is traditionally known as the active compound in marijuana. It has hallucinogenic properties and is what gives users the feeling of being “high”.

But CBD is on another plane of existence entirely.

When it comes to cannabis and psychoactivity, first I need to talk about the body’s cannabinoid 1 (CB1) receptors. CB1 receptors are chemical receptors located in the brain and spinal cord.

The fundamental difference between CBD and THC is how each one interacts with the CB1 receptors in the body. THC binds well with CB1 receptors, while CBD doesn’t. This difference allows medical professionals to isolate CBD compounds and utilize them in therapies without the risk of hallucinogenic side effects.

Multiple scientific studies have shown that CBD derivatives have a marked effect in curing or reducing symptoms for a number of diseases and ailments.

The scientific fact is CBD won’t get you high. Neither will medicinal products that isolate CBD — supplements, oils, tinctures, patches.

The Early Mover Gets the Fortune

It’s become increasingly difficult to ignore the raw scientific data surrounding marijuana and CBD studies.

The number of diseases being treated with medical marijuana is mind-boggling. For brevity’s sake, here’s a quick list:

  • Sleep disorders
  • Pain management
  • Parkinson’s
  • Arthritis
  • Hypertension
  • Anxiety
  • Autism
  • Opioid addiction.

Odds are you know a friend or family member who suffers from one these. Perhaps even you. Unfortunately, many people suffering from these and other ailments have no access to the medicine they need.

The good news is the prohibition narrative is waning.

Medical marijuana is a thriving industry that is not only helping thousands get well, but also putting a lot of cash in investors’ pockets. Legal pot is pumping huge amounts of cash back into state budgets through tax dollars and other regulatory fees.

Politicians and lawmakers can’t ignore the bottom line forever and neither should you.

Pot is a big cash business.

As tax revenue starts piling up and prohibition states continue to struggle financially, the benefits of a thriving medical marijuana industry will become plainly obvious.

Which in turn makes medical marijuana a highly profitable industry for you too. As legalization rolls on here and across the globe, the early movers who get in on the ground floor will soon be rolling in dough.

For Tomorrow’s Trends Today,

Sean McCloskey
for The Daily Reckoning

You May Also Be Interested In:

Get Ready for Election Cycle Drama

Good morning – so half the year has gone by already… and if you’re like me – I’m happy to say good riddance… Who would’ve thought what happened (and is still happening) could really have happened? I mean think about it – but to do so you have to go back to early 2018 when the administration embarked on new trade negotiations with China – it what became known as the US/China Trade War…